Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK–mTOR pathway
Shaoren Zhang, Yuqing Mao, Xiaoming Fan Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, China Background: Nonalcoholic fatty liver disease (NAFLD) has been considered the most commonly occurring chronic hepatopathy in the world. Ghrelin o-acyltransfer...
Main Authors: | Zhang S, Mao Y, Fan X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibition-of-ghrelin-o-acyltransferase-attenuated-lipotoxicity-by-ind-peer-reviewed-article-DDDT |
Similar Items
-
Ghrelin octanoylation by ghrelin O-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling
by: Tasha R. Davis, et al.
Published: (2021-07-01) -
Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress
by: Samah Alharbi
Published: (2022-07-01) -
Discovery of novel inhibitors of ghrelin O-acyltransferase enzyme: an in-silico approach
by: Faezeh Sadat Hosseini, et al.
Published: (2022-01-01) -
JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis
by: Chihiro Okuma, et al.
Published: (2015-07-01) -
Novel regulator of acylated ghrelin, CF801, reduces weight gain, rebound feeding after a fast, and adiposity in mice
by: Martin K Wellman, et al.
Published: (2015-09-01)